chansin

IP属地:未知
    • chansinchansin
      ·2021-12-16
      5 Tech Stocks Seeing Massive Insider Buying
      1,030评论
      举报
    • chansinchansin
      ·2021-11-10
      Skillz to Participate in RBC Capital Markets Technology, Internet, Media and Telecom ConferenceWed, November 10, 2021, 5:15 AM · 1 min readIn this article:
      1,325评论
      举报
    • chansinchansin
      ·2021-11-09
      Sorrento Awarded California Competes Tax CreditSorrento Therapeutics, Inc.Mon, November 8, 2021, 2:08 AM · 4 min read
      552评论
      举报
    • chansinchansin
      ·2021-11-09
      Nano Dimension Announces New DragonFly IV 3D-Printer and FLIGHT Software Package.Nano Dimension Ltd.Mon, November 8, 2021, 9:00 PM · 5 min readIn this article:
      475评论
      举报
    • chansinchansin
      ·2021-11-08
      Nano Dimension Acquires Essemtec AG, Surface-Mount Pick & Place Systems Supplier for the PCB and OEM IndustriesGlobeNewswire2021-11-03 13:00Nano Dimension+0.86%Post
      6021
      举报
    • chansinchansin
      ·2021-11-05
      Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of Ocugen’s COVID-19 vaccine candidate BBV152, known as COVAXIN™ outside of the U.S., for pediatric use. The vaccine candidate was developed by the company’s partner, Bharat Biotech, and was studied in an immuno-bridging clinical trial conducted in India with children 2-18 years of age
      @me168
      $Histogenics(OCGN)$https://youtu.be/TUMlkkCBPfY start listening from 2h18min mark. Let Dr Fauci answer our doubts
      $Histogenics(OCGN)$https://youtu.be/TUMlkkCBPfY start listening from 2h18min mark. Let Dr Fauci answer our doubts
      922评论
      举报
    • chansinchansin
      ·2021-11-05
      Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of Ocugen’s COVID-19 vaccine candidate BBV152, known as COVAXIN™ outside of the U.S., for pediatric use. The vaccine candidate was developed by the company’s partner, Bharat Biotech, and was studied in an immuno-bridging clinical trial conducted in India with children 2-18 years of age
      @Yanningxd
      $Histogenics(OCGN)$BWAHAHAHAHA cover this shorties
      $Histogenics(OCGN)$BWAHAHAHAHA cover this shorties
      910评论
      举报
    • chansinchansin
      ·2021-11-05
      Like

      摩根大通推荐了12只东南亚股票,你最看好谁?

      @孟浩
      摩根大通刚刚更新了11月的亚洲股票推荐清单,除了$Sea Ltd(SE)$ $星展集团控股(D05.SI)$ 之外,还有谁?让我们一起来看看,欢迎大家给我回复,说说哪个股票值得买入?$星展集团控股(D05.SI)$ ,相信虎友对它都很了解,是东南亚三大银行之一,也是新交所市值最大的公司,过去五年的平均股息达4.3%,过去十年的平均年化回报率达10%。摩根大通看好他的原因主要是因为其财务管理服务扩大,以及数字化程度提高。此外,星展银行曾预计到今年年底其加密货币交易规模将增加1倍。随着数字货币增长,未来3年每年将增长20%-30%。 $Sea Ltd(SE)$ 是一家消费互联网公司。公司建立了一个集数字娱乐、电子商务、数字金融服务于一体的综合平台。Sea旗下三大业务包括数字游戏(Garena)、电子商务(Shopee)、数字金融(SeaMoney),其游戏与电商业务在东南亚位居龙头之位。摩根大通看好他的原因主要是因为其电商业务收入增长,亏损减少,此外Garena还推出自研「吃鸡」游戏FreeFire,从2017年开始持续贡献玩家与流水,成为最火热爆款游戏。截止2021年Q2,Garena季度活游戏用户规模达到7.25亿人,成为绝对的东南亚游戏市场龙头。 $Ayala Corp.(AYALY)$ 是菲律宾历史最悠久、规模最大的企业集团。该公司拥有多种多样的商业利益,包括在零售、教育、房
      摩根大通推荐了12只东南亚股票,你最看好谁?
      6516
      举报
    • chansinchansin
      ·2021-11-04
      Once Taboo, SPACs Are Now the Main Driver of Fundraising and New Growth in CannabisStreetInsider2021-11-02 08:08
      1,542评论
      举报
    • chansinchansin
      ·2021-11-02
      BRIEF-Aldeyra Therapeutics Announces Achievement Of Primary Endpoint Of Ocular Redness In Mid-Stage Study In Dry Eye DiseaseReuters2021-11-02 20:06Aldeyra Therapeutics-7.47%
      441评论
      举报
     
     
     
     

    热议股票